Abstract
The paper examines the main issues of integrated treatment of resectable breast cancer. Identifies underlying prognostic factors and the relation between the choice of systemic therapy on the molecular characteristics of tumours. In the evolutionary aspect different approaches, both local and systemic treatments of patients with resectable primary breast cancer are assessed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have